Multifocal Organoid Capturing of Colon Cancer Reveals Pervasive Intratumoral Heterogenous Drug Responses

Abstract

Intratumor heterogeneity (ITH) stands as one of the main difficulties in the treatment of colorectal cancer (CRC) as it causes the development of resistant clones and leads to heterogeneous drug responses. Here, 12 sets of patient-derived organoids (PDOs) and cell lines (PDCs) isolated from multiple regions of single tumors from 12 patients, capturing ITH by multiregion sampling of individual tumors, are presented. Whole-exome sequencing and RNA sequencing of the 12 sets are performed. The PDOs and PDCs of the 12 sets are also analyzed with a clinically relevant 24-compound library to assess their drug responses. The results reveal unexpectedly widespread subregional heterogeneity among PDOs and PDCs isolated from a single tumor, which is manifested by genetic and transcriptional heterogeneity and strong variance in drug responses, while each PDO still recapitulates the major histologic, genomic, and transcriptomic characteristics of the primary tumor. The data suggest an imminent drawback of single biopsy-originated PDO-based clinical diagnosis in evaluating CRC patient responses. Instead, the results indicate the importance of targeting common somatic driver mutations positioned in the trunk of all tumor subregional clones in parallel with a comprehensive understanding of the molecular ITH of each tumor.

Multifocal organoids reveal clonal associations between synchronous intestinal tumors with pervasive heterogeneous drug responses

“…Both tissue and organoid sections were subjected to H&E as well as immunohistochemical (IHC) staining. The procedure of IHC is as previously described 42 . Antibodies used for IHC are summarized as follows:…”

Spheroids and organoids derived from colorectal cancer as tools for in vitro drug screening

“…The co-culture CRC spheroids showed great sensitivity to phosphatidylinositol 3-kinase (PI3K) inhibitor, LY294002 with dramatic decline of tumor growth [ 64 ]. The developed 3D triculture CRC spheroid model constituted of HCT116 cells, human intestinal fibroblasts, and primary monocytes which transdifferentiated into macrophages was tested for Nutlin 3a (Nut3a) and compared with 2D models [ 69 ]. The 3D spheroid model showed an anti-proliferative effect but not at a higher extent as shown in 2D model.…”

Gasdermin E plasmid DNA/indocyanine green coloaded hybrid nanoparticles with spatiotemporal controllability to induce pyroptosis for colon cancer treatment

“…Colorectal cancer (CRC) is one of the most commonly diagnosed tumors of the gastrointestinal track, with high morbidity and mortality, [1][2][3] which is prone to tumor metastasis and recurrence. 4 Surgery shows favorable efficacy in the early stages of CRC.…”